US: BioIVT acquires serum, plasma and reagent producer
BioPharma Reporter
JUNE 29, 2021
The New York based company said the deal will expand its in vitro diagnostic, cell and gene therapy support capabilities.
BioPharma Reporter
JUNE 29, 2021
The New York based company said the deal will expand its in vitro diagnostic, cell and gene therapy support capabilities.
Drug Discovery World
MAY 16, 2023
What are the global innovations in cell and gene therapy? What opportunities and challenges are emerging and can therapies get to market faster? Curbishley explains that as the wave of new therapies in development continues to increase, global pressures on manufacturing availability will become more acute.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Discovery World
APRIL 3, 2023
As the industry moves to reduce the use of animals in research and testing, aptamers also support here, as they are discovered, developed, and manufactured entirely in vitro , removing the need for animals in antibody discovery processes. DDW’s Diana Spencer caught up with co-founder and CEO Dr Arron Tolley.
Drug Discovery World
OCTOBER 13, 2022
Over the two days at ExCel, 1554 delegates attended the event. Of those delegates, 75% work in drug discovery. There were 127 exhibitors, 180 posters, 40 technology speakers, 52 scientific speakers as well as a series of eight seminars focused on automation and technology which DDW organised and moderated in the dedicated Tech Theatre. .
Drug Discovery World
FEBRUARY 27, 2023
which removes the mandatory requirement for animal testing in the development of drugs for toxicity where enhanced performance is proven using in vitro alternatives. The technology offers features for cell and gene therapy developers and manufacturers, such as end stage deployment at the clinic or hospital.
Let's personalize your content